Malignant blood disorders
Adult: Initially: 175-300 mg/m2 given in divided doses over 3-7 consecutive days via IV infusion over 30-60 minutes. Maintenance: 25-100 mg/m2 in a single infusion every 3-4 wk.
Pregnancy, lactation; CV disease.
Warnings / Precautions
Myocardial irradiation and use of radiotherapy. Hepatic or renal impairment. Elderly.
Adverse Reactions
Nausea, vomiting, mucositis, irritant to tissue, sore mouth, bone-marrow suppression, hyperuricaemia. Alopoecia (rare).
Potentially Fatal: Cardiotoxicity (rare), myelosuppression in patients who received mitomycin or a nitrosourea, leucopenia.
Drug Interactions
Other cardiotoxic drugs e.g. daunorubicin or cyclophosphamide, live vaccines; decreases effects of digoxin, oral anticoagulants, phenytoin and suxamethonium.
See Below for More aclarubicin Drug Interactions
Lab Interactions
Elevated bilirubin level.
Mechanism of Actions
Aclarubicin is an anthracycline, a cytotoxic antibiotic, and inhibits RNA synthesis through intercalation.
Distribution: Rapidly distributed into tissues after IV admin.
Metabolism: Extensively metabolised.
Excretion: Triphasic clearance. Terminal elimination half-life: About 3 hr. Excreted in urine mainly as metabolites.
ATC Classification
L01DB04 - aclarubicin ; Belongs to the class of cytotoxic antibiotics, anthracyclines and related substances. Used in the treatment of cancer.
Available As
  • Aclarubicin 20 mg
  • Subscribe for latest updates

    Subscribe to our e-mail newsletter to receive updates.

    No comments yet.

    Post Review about Aclarubicin

    Aclarubicin Containing Brands

    We are Developing Our database, More results coming soon.

    Aclarubicin is used in following diseases

    We are Developing Our database, More results coming soon.

    Drug - Drug Interactions of Aclarubicin

    We are Developing Our database, More results coming soon.